1. Home
  2. USNA vs LRMR Comparison

USNA vs LRMR Comparison

Compare USNA & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$19.76

Market Cap

371.5M

Sector

Health Care

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$3.90

Market Cap

332.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
LRMR
Founded
1992
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
371.5M
332.1M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
USNA
LRMR
Price
$19.76
$3.90
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$36.00
$16.71
AVG Volume (30 Days)
146.1K
1.3M
Earning Date
10-22-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$912,670,000.00
N/A
Revenue This Year
$9.80
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.95
N/A
Revenue Growth
5.88
N/A
52 Week Low
$18.48
$1.61
52 Week High
$38.32
$5.37

Technical Indicators

Market Signals
Indicator
USNA
LRMR
Relative Strength Index (RSI) 45.40 53.26
Support Level $19.44 $3.34
Resistance Level $20.03 $4.01
Average True Range (ATR) 0.53 0.24
MACD -0.01 0.02
Stochastic Oscillator 20.53 69.14

Price Performance

Historical Comparison
USNA
LRMR

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: